Several preclinical glaucoma models (e.g., induced ocular hypertension in rats) showed that topical or intraocular NGF administration did not cause further intraocular pressure elevation; instead, it promoted retinal ganglion cell survival, inhibited apoptosis, and supported functional recovery [226]. This evidence concerns the gene NGF and glaucoma.